Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Yicong, Bian"'
Autor:
Hua Zhang, Shu Yan, Yan Zhan, Sheng Ma, Yicong Bian, Shaorong Li, Junjun Tian, Guangze Li, Dafang Zhong, Xingxing Diao, Liyan Miao
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
SHR6390 (dalpiciclib) is a selective and effective cyclin-dependent kinase (CDK) 4/6 inhibitor and an effective cancer therapeutic agent. On 31 December 2021, the new drug application was approved by National Medical Product Administration (NMPA). Th
Externí odkaz:
https://doaj.org/article/9ade4cd4b236434a9d6b7b2f8081e130
Autor:
Yicong Bian, Minzhou Huang, Sheng Ma, Linsheng Liu, Fan Xia, Zhiyao Chen, Di Yu, Chenrong Huang, Liyan Miao, Yuanyuan Ji
Publikováno v:
Chinese Medical Journal, Vol 135, Iss 11, Pp 1383-1385 (2022)
Externí odkaz:
https://doaj.org/article/2ed0792ae3a044b985b5988b04ca0fac
Autor:
Yan Wang, Donghui Pan, Chenrong Huang, Bingliang Chen, Mingzhu Li, Shuaixiang Zhou, Lizhen Wang, Min Wu, Xinyu Wang, Yicong Bian, Junjie Yan, Junjian Liu, Min Yang, Liyan Miao
Publikováno v:
mAbs, Vol 12, Iss 1 (2020)
Selecting the dose for efficacy and first-in-human studies of bispecific antibodies (BsAbs) is a challenging process. Herein, positron emission tomography (PET) imaging with 89Zr-labeled IBI322, an anti-CD47/PD-L1 BsAb, was used to optimize the safet
Externí odkaz:
https://doaj.org/article/f20e199e2cd74d2bb487593d53b9eae9
Autor:
Yan Wang, Chao Wang, Minzhou Huang, Songbing Qin, Jun Zhao, Shibiao Sang, Meng Zheng, Yicong Bian, Chenrong Huang, Hua Zhang, Lingchuan Guo, Jiwei Jiang, Chun Xu, Na Dai, Yushuang Zheng, Jiajun Han, Min Yang, Tao Xu, Liyan Miao
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 49:4394-4405
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::166eb7b8c311d81a55da8788f91813da
https://doi.org/10.1007/s00259-022-05903-9
https://doi.org/10.1007/s00259-022-05903-9
Autor:
Zheming Gu, Zhenwen Yu, Tong Wang, Yating Xiong, Xusheng Tian, Hua Zhang, Jinsong Ding, Qiang Yu, Jinmiao Lu, Zengyan Xu, Juping Ding, Xinyi Zhou, Yicong Bian, Dong Tang
Publikováno v:
Xenobiotica. 52:38-45
1. The metabolism and excretion of cetagliptin were investigated in healthy male subjects after a single oral dose of 100mg/50μCi [14C] cetagliptin.2. The mean concentration-time profile of cetagliptin was similar to that of total radioactivity in p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::485489eb847ea0003b8b01ab33de173b
https://doi.org/10.1080/00498254.2021.2002973
https://doi.org/10.1080/00498254.2021.2002973
Publikováno v:
European journal of drug metabolism and pharmacokinetics. 47(6)
Nucleobase and nucleoside analogs (NAs) play important roles in cancer therapy. Although there are obvious individual differences in NA treatments, most NAs lack direct relationships between their plasma concentration and efficacy or adverse effects.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61cb306e7861fa7ab38066ab30ea80e8
https://pubmed.ncbi.nlm.nih.gov/35915365
https://pubmed.ncbi.nlm.nih.gov/35915365
Autor:
Liyan Miao, Sheng Ma, Shiping Ma, Yicong Bian, Xiao Liu, Chenrong Huang, Hua Zhang, Zheming Gu, Yating Xiong, Zhenwen Yu, Pangke Yan, Yongyi Jiao
Publikováno v:
British Journal of Clinical Pharmacology. 87:93-105
Aims This trial (NCT03751956) investigated the mass balance, pharmacokinetics and pharmacodynamics of HSK3486, a novel anaesthetic, in healthy subjects. Methods A single dose of 0.4 mg/kg [14 C]HSK3486 was administered to six healthy subjects. Blood,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca7ff4e31a1501a5729f1822ff7b4a6d
https://doi.org/10.1111/bcp.14363
https://doi.org/10.1111/bcp.14363
Autor:
Chenrong Huang, Yicong Bian, Liyan Miao, Xiaoxue Liu, Wenhao Qu, Jun Cao, Linsheng Liu, Xianglian Li
Publikováno v:
Expert Opinion on Drug Metabolism & Toxicology. 16:527-537
Rifampin (RIF), isoniazid (INH) and pyrazinamide (PZA) are essential components of the short-term first-line anti-tuberculosis (anti-TB) chemotherapy regimen and can cause hepatotoxicity. However, the mechanism of anti-TB drug-induced hepatotoxicity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3a3e7e9f1e8cbc6082afc3bcb9090c4
https://doi.org/10.1080/17425255.2020.1758060
https://doi.org/10.1080/17425255.2020.1758060
Autor:
Yan Wang, Chao Wang, Minzhou Huang, Songbin Qin, Jun Zhao, Shibiao Sang, Meng Zheng, Yicong Bian, Chenrong Huang, Hua Zhang, Linchuan Guo, Jiwei Jiang, Chun Xu, Na Dai, Yushuang Zheng, Jiajun Han, Min Yang, Tao Xu, Liyan Miao
Purpose Positron emission tomography (PET) with specific diagnostic probes for quantifying CD8+ T cells has emerged as a powerful technique for monitoring immune response. However, currently, most CD8+ T cell radiotracers are based on antibodies or a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23ede62fa145b124d8a24f27e2ba821b
https://doi.org/10.21203/rs.3.rs-1554814/v1
https://doi.org/10.21203/rs.3.rs-1554814/v1
Autor:
Yan, Wang, Chao, Wang, Minzhou, Huang, Songbing, Qin, Jun, Zhao, Shibiao, Sang, Meng, Zheng, Yicong, Bian, Chenrong, Huang, Hua, Zhang, Lingchuan, Guo, Jiwei, Jiang, Chun, Xu, Na, Dai, Yushuang, Zheng, Jiajun, Han, Min, Yang, Tao, Xu, Liyan, Miao
Publikováno v:
European journal of nuclear medicine and molecular imaging. 49(13)
Positron emission tomography (PET) with specific diagnostic probes for quantifying CD8sup+/supT cells has emerged as a powerful technique for monitoring the immune response. However, most CD8sup+/supT cell radiotracers are based on antibodies or anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5eb46580a74e987ecc810fa79b797196
https://pubmed.ncbi.nlm.nih.gov/35829748
https://pubmed.ncbi.nlm.nih.gov/35829748